skip to main content


Jan 19, 2022

Janssen v Pharmascience

Featuring: Megan Pocalyuko, Peter Wilcox and Marian Wolanski

We successfully represented Janssen in this summary trial in the Federal Court on infringement issues against Pharmascience in respect of Janssen’s patent covering its important INVEGA SUSTENNA® (paliperidone palmitate) once-monthly injection product used to treat schizophrenia. This decision represents a significant advance in the application of the law relating to induced infringement.


  • Patents

© 2015 Belmore Neidrauer LLP | Legal Disclaimer | Privacy Policy